首页 | 本学科首页   官方微博 | 高级检索  
     

脂联素与冠状动脉粥样硬化性心脏病临床研究进展
引用本文:林鸿. 脂联素与冠状动脉粥样硬化性心脏病临床研究进展[J]. 医学综述, 2012, 18(3): 354-356
作者姓名:林鸿
作者单位:昆明医学院第二附属医院心内科,云南省心血管病研究所冠心病基础研究室,昆明,650101
摘    要:
冠状动脉粥样硬化性心脏病严重威胁人类的健康,脂联素(APN)与冠状动脉粥样硬化性心脏病密切相关。APN的基因多态性及其分泌部位的不同与冠状动脉粥样硬化性心脏病的发病相关。APN的血浆浓度可预测冠状动脉粥样硬化性心脏病及其预后。APN的抗炎及稳定斑块的作用可以治疗冠状动脉粥样硬化性心脏病。现就近年来国内外有关APN与冠状动脉粥样硬化性心脏病的预测,诊断及治疗的相关文献予以综述。

关 键 词:冠状动脉粥样硬化性心脏病  脂联素  临床研究

Clinical Research Progress in Adiponectin and Coronary Atherosclerotic Heart Disease
LIN Hong. Clinical Research Progress in Adiponectin and Coronary Atherosclerotic Heart Disease[J]. Medical Recapitulate, 2012, 18(3): 354-356
Authors:LIN Hong
Affiliation:.(Department of Heart Medicine,the Second Affiliated Hospital of Kunming Medical College,Basic Research Lab of Coronary Heart Disease of Yunnan Institute of Cardiovascular Disease,Kunming 650101,China)
Abstract:
At present,coronary atherosclerotic heart disease(CAHD)seriously threatens the health of people.Adiponectin(APN)has a close relationship with CAHD,specifically,APN gene polymorphisms and different secretion positions are related with CAHD.Plasma adiponectin level is an independent predictor and prognostic factor of CAHD.Anti-inflammatory action and affectively prevent necrotic core plaque formation of adiponectin may be applied to treat CAHD.Here is to make a review on the literature of prediction,diagnosis and treatment of CAHD in China and overseas in recent years.
Keywords:Coronary atherosclerotic heart disease  Adiponectin  Clinical research
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号